Back to top
more

Coty (COTY)

(Delayed Data from NYSE)

$9.26 USD

9.26
3,057,688

0.00 (0.00%)

Updated Sep 18, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (171 out of 251)

Industry: Cosmetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

New York-based Coty Inc., along with its subsidiaries, manufactures, markets, and distributes beauty products worldwide. The company sells its products through retailers, including hypermarkets, supermarkets, independent and chain drug stores and pharmacies, upscale perfumeries, upscale and mid-tier department stores, nail salons, specialty retailers, duty-free shops and traditional food, and drug and mass retailers. It also markets products under the Astor, Coty, Joop!, Jovan, Manhattan, and N.Y.C. New York Color brands.

Ansuiya Mohta headshot

EL Trading Near 52-Week Low: How Should Investors Approach the Stock?

by Ansuiya Mohta

EL is battling weak consumer sentiment, market instability and currency woes. The company is making some progress with its Profit Recovery and Growth Plan.

Coty Thrives in the Growing Beauty Space Despite Cost Challenges

by Zacks Equity Research

COTY continues to benefit from robust growth in the global beauty market, driven by a strong brand presence and consumer demand.

Coty (COTY) Reliance on International Sales: What Investors Need to Know

by Zacks Equity Research

Review Coty's (COTY) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

COTY's Q4 Loss Wider Than Estimates, Sales Increase Y/Y

by Zacks Equity Research

COTY's fourth-quarter fiscal 2024 results reflect growth in the Consumer Beauty segments. However, the bottom line declines year over year.

Coty (COTY) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

Although the revenue and EPS for Coty (COTY) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Coty (COTY) Reports Q4 Loss, Lags Revenue Estimates

by Zacks Equity Research

Coty (COTY) delivered earnings and revenue surprises of -175% and 0.94%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Estee Lauder (EL) Q4 Earnings and Revenues Top Estimates

by Zacks Equity Research

Estee Lauder (EL) delivered earnings and revenue surprises of 156% and 0.99%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

COTY Gears Up for Q4 Earnings Release: Things to Keep in Mind

by Zacks Equity Research

COTY's fiscal fourth-quarter performance is likely to reflect gains from momentum in the global beauty market. However, a rising cost environment might be a hurdle.

What Analyst Projections for Key Metrics Reveal About Coty (COTY) Q4 Earnings

by Zacks Equity Research

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Coty (COTY), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.

Ansuiya Mohta headshot

4 Cosmetics Stocks Worth Watching Amid Industry Challenges

by Ansuiya Mohta

The Zacks Cosmetics industry is grappling with elevated inflationary pressures. Coty, Inter Parfums (IPAR), Waldencast (WALD) and Olaplex (OLPX) are capitalizing on digital advancements and innovative strategies.

Flowers Foods (FLO) Q2 Earnings in the Cards: Things to Note

by Zacks Equity Research

Flowers Foods' (FLO) second-quarter 2024 performance is likely to reflect gains from portfolio strength, while high SD&A costs and a volatile consumer landscape are concerns.

Coty (COTY) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Coty (COTY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BRF S.A. (BRFS) Q2 Earnings in the Cards: Things to Consider

by Zacks Equity Research

BRF S.A.'s (BRFS) second-quarter 2024 performance will likely reflect gains from the BRF+ program and stable feed costs.

E.l.f. Beauty (ELF) Surpasses Q1 Earnings and Revenue Estimates

by Zacks Equity Research

e.l.f. Beauty (ELF) delivered earnings and revenue surprises of 32.53% and 6.88%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Sally Beauty (SBH) Q3 Earnings in the Cards: Things to Note

by Zacks Equity Research

Sally Beauty's (SBH) third-quarter fiscal 2024 performance will likely reflect the adverse impact of a decline in customer traffic and inflationary pressures.

Nu Skin (NUS) Set to Report Q2 Earnings: What to Expect?

by Zacks Equity Research

Nu Skin's (NUS) Q2 results are likely to reflect the impacts of macroeconomic challenges, including inflation and adverse currency fluctuations.

Inter Parfums (IPAR) Q2 Earnings in the Cards: Things to Note

by Zacks Equity Research

Inter Parfums' (IPAR) second-quarter performance is likely to reflect strong momentum in the fragrance market, supported by robust sales from its new licenses. High SG&A costs are a threat.

Monster Beverage's (MNST) Q2 Earnings Coming Up: Things to Note

by Zacks Equity Research

Monster Beverage's (MNST) second-quarter 2024 results are likely to reflect gains from strength in its energy drinks category and product launches.

B&G Foods' (BGS) Q2 Earnings in the Cards: Factors to Watch

by Zacks Equity Research

B&G Foods' (BGS) Q2 results are likely to reflect the impacts of category-wide challenges across the food industry and high SG&A costs.

Can Molson Coors' (TAP) Strategies Outrun Inflation Woes in Q2?

by Zacks Equity Research

Molson Coors' (TAP) strategic investments and premiumization efforts drive robust growth amid industry challenges and inflationary pressures. Let us see how the Q2 performance is likely to have been.

Medifast (MED) Q2 Earnings in the Cards: Factors to Watch

by Zacks Equity Research

Medifast's (MED) Q2 results are likely to reflect customer acquisition challenges stemming from the growth of GLP-1 medications in markets.

Factors to Watch Before TreeHouse Foods' (THS) Q2 Earnings

by Zacks Equity Research

TreeHouse Foods' (THS) Q2 results are likely to reflect challenges such as the restart of the broth facility, along with the lag in pricing adjustments to counter cocoa inflation.

Kellanova (K) Q2 Earnings Coming Up: Key Factors to Consider

by Zacks Equity Research

Kellanova's (K) second-quarter performance is likely to reflect the impacts of elevated inflation rates and industry-wide elasticities. Unfavorable foreign currency rates pose a threat.

What's in Store for Church & Dwight's (CHD) Q2 Earnings Report?

by Zacks Equity Research

Church & Dwight's (CHD) robust portfolio built through innovation, new products, and acquisitions positions it well for Q2 earnings amid escalated marketing expenses and inflationary headwinds.

Tyson Foods (TSN) Q3 Earnings in the Cards: Things to Note

by Zacks Equity Research

Tyson Foods (TSN) Q3 performance will likely reflect gains from growing protein demand. However, a tight cattle supply environment might have been a spoilsport.